According to our latest research, the global Amyotrophic Lateral Sclerosis (ALS) Treatment market size was valued at USD 684 million in 2024, with a robust compound annual growth rate (CAGR) of 5.8% expected during the forecast period. By 2033, the market is projected to reach approximately USD 1,210 million, driven by advancements in drug development, increased awareness, and rising prevalence rates worldwide. The marketÂ’s expansion is further propelled by ongoing research into novel therapies and the growing integration of multidisciplinary care approaches, which together are significantly improving patient outcomes and quality of life.
https://growthmarketreports.co....m/report/amyotrophic
처럼
논평
공유하다